Logo for LIDDS

LIDDS Investor Relations Material

Latest events

Logo for LIDDS

Q3 2023

28 Nov, 2023
Logo for LIDDS

Q2 2023

30 Aug, 2023
Access the full event backlog
Slides, Transcripts, and Reports from over 8,000 public companies
LIDDS AB is a pharmaceutical company, which develops and sells pharmaceutical products for cancer and other diseases in Sweden. It produces various drugs, such as NZ-2HOF to treat prostate cancer; NZ-DTX to treat breast, prostate, head, neck, stomach and lung cancer; NZ-DOX for the treatment of solid tumors; NZ-IO for the treatment of metastatic colorectal cancer; NZ-STING for the treatment of immuno-oncology; and NZ-TLR9 for enhancing cancer immunotherapies. The company has collaboration with PharmIdea SIA to focus on anti-cancer drugs and sterile formulations. LIDDS AB is based in Uppsala, Sweden.